Targeting DNA Repair in Prostate Cancer

被引：4
作者：
Abida, Wassim [1 ]
Sawyers, Charles L. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 10期
关键词：
INCREASED SURVIVAL; ORGANOID CULTURES; EWINGS-SARCOMA; CHEMOTHERAPY; OLAPARIB; CELLS; IDENTIFICATION; ENZALUTAMIDE; SENSITIVITY; ABIRATERONE;
D O I：
10.1200/JCO.2017.76.6592
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1017 / +
页数：5
相关论文
共 50 条
  • [31] Emerging therapies targeting castration-resistant prostate cancer
    Gkialas, Ioarmis K.
    Fragkoulis, Charalampos
    JOURNAL OF BUON, 2015, 20 (06): : 1389 - 1396
  • [32] Novel drugs targeting the androgen receptor pathway in prostate cancer
    Mateo, Joaquin
    Smith, Alan
    Ong, Michael
    de Bono, Johann S.
    CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 567 - 579
  • [33] Implications of DNA damage repair alterations for the management of prostate cancer
    Lozano, Rebeca
    Olmos, David
    Castro, Elena
    CURRENT OPINION IN UROLOGY, 2022, 32 (03) : 302 - 310
  • [34] Apalutamide Sensitizes Prostate Cancer to Ionizing Radiation via Inhibition of Non-Homologous End-Joining DNA Repair
    Zhang, Wenhao
    Liao, Chen-Yi
    Chtatou, Hajar
    Incrocci, Luca
    van Gent, Dik C.
    van Weerden, Wytske M.
    Nonnekens, Julie
    CANCERS, 2019, 11 (10)
  • [35] Study of novel ginsenoside metabolites targeting HSP70 as anti-prostate cancer drugs
    Xu, Lei
    Xiao, Shengnan
    Chai, Zhi
    Li, Tao
    Lee, Jung Joon
    Su, Guangyue
    Zhao, Yuqing
    BIOORGANIC CHEMISTRY, 2024, 144
  • [36] Targeting the androgen receptor in the management of castration-resistant prostate cancer: rationale, progress, and future directions
    Leibowitz-Amit, R.
    Joshua, A. M.
    CURRENT ONCOLOGY, 2012, 19 : S22 - S31
  • [37] Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 997 - +
  • [38] Targeting the microRNA-regulating DNA damage/repair pathways in cancer
    Bottai, Giulia
    Pasculli, Barbara
    Calin, George A.
    Santarpia, Libero
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (11) : 1667 - 1683
  • [39] Nivolumab in Patients with Metastatic Castration-Resistant Prostate Cancer with and without DNA Repair Defects
    Velho, Pedro Isaacsson
    Bastos, Diogo Assed
    Saint'ana, Pedro Tofani
    Rigatti, Brenda
    da Costa, Emily Tonin
    Muniz, David Q. B.
    Andreis, Felipe
    Ferreira, Rafael Dal Ponte
    Pedrotti, Luana Giongo
    Maistro, Simone
    Katayama, Maria Lucia Hirata
    Folgueira, Maria Aparecida Azevedo Koike
    Morelle, Alessandra
    Leal, Alessandro
    de Castro, Gilberto
    CLINICAL CANCER RESEARCH, 2024, 30 (23) : 5342 - 5352
  • [40] Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
    Broustas, Constantinos G.
    Duval, Axel J.
    Chaudhary, Kunal R.
    Friedman, Richard A.
    Virk, Renu K.
    Lieberman, Howard B.
    ONCOGENE, 2020, 39 (12) : 2467 - 2477
12345